相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: Relationship with histopathological and molecular classifications
Yutaka Kurebayashi et al.
HEPATOLOGY RESEARCH (2021)
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?
Eleonora Lai et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Role of chemokines in hepatocellular carcinoma
Dongdong Xue et al.
ONCOLOGY REPORTS (2021)
Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases
Eirini I. Rigopoulou et al.
CANCERS (2021)
A case with hepatic immune-related adverse events caused by nivolumab exhibiting impaired accumulation of regulatory T cells
Ikue Sekai et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2021)
Mechanistic classification of immune checkpoint inhibitor toxicity as a pointer to minimal treatment strategies to further improve survival
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma
Santosh K. Singh et al.
CANCERS (2020)
Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma
Nada Chaoul et al.
CANCERS (2020)
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
Chunxiao Li et al.
MOLECULAR CANCER (2020)
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
Christo Kole et al.
CANCERS (2020)
Immune surveillance of the liver by T cells
Xenia Ficht et al.
SCIENCE IMMUNOLOGY (2020)
Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
Francesco Tovoli et al.
VACCINES (2020)
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors
Eleonora De Martin et al.
JHEP REPORTS (2020)
EASL Clinical Practice Guidelines: Drug-induced liver injury
Raul J. Andrade et al.
JOURNAL OF HEPATOLOGY (2019)
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment
Kazuo Tarao et al.
CANCER MEDICINE (2019)
Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
Jian Chen et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma
Catrin Tauber et al.
Oncotarget (2019)
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study
Alice Tison et al.
ARTHRITIS & RHEUMATOLOGY (2019)
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
Jiaqiang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The risk of liver cancer in autoimmune liver diseases
Ana Lleo et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease A Systematic Review
Noha Abdel-Wahab et al.
ANNALS OF INTERNAL MEDICINE (2018)
Myeloid Cells and Chronic Liver Disease: a Comprehensive Review
Min Lian et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
Francois-Xavier Danlos et al.
EUROPEAN JOURNAL OF CANCER (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
Eleonora De Martin et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity
Silvia Piconese et al.
JOURNAL OF AUTOIMMUNITY (2018)
Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma A meta-analysis
Wei Ding et al.
MEDICINE (2018)
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
Le-Xing Yu et al.
NPJ PRECISION ONCOLOGY (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy
Hanmin Li et al.
ONCOTARGET (2017)
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012
Donna L. White et al.
GASTROENTEROLOGY (2017)
Tregs restrain dendritic cell autophagy to ameliorate autoimmunity
Themis Alissafi et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection
Laura J. Pallett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Austin G. Duffy et al.
JOURNAL OF HEPATOLOGY (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Is autoimmunity the Achilles' heel of cancer immunotherapy?
Carl H. June et al.
NATURE MEDICINE (2017)
Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4
Xin Chen et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior
Xi Cheng et al.
SCIENTIFIC REPORTS (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis
Aylin Tansel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
Daphne Day et al.
BIODRUGS (2016)
Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
Yi-Peng Fu et al.
BRITISH JOURNAL OF CANCER (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
The rationale for targeting TGF-β in chronic liver diseases
Gianluigi Giannelli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
CD4+CD25+regulatory T cells in tumor immunity
Xin Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2016)
Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer
Li Ren et al.
ONCOTARGET (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response
Bryony Simmons et al.
CLINICAL INFECTIOUS DISEASES (2015)
Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis
Pascal Lapierre et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Roles for Chemokines in Liver Disease
Fabio Marra et al.
GASTROENTEROLOGY (2014)
Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction
Christian A. Bauer et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
Effect of liver regeneration on malignant hepatic tumors
Ji-Hua Shi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy
Isabela Pedroza-Pacheco et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients
Fu-Jun Li et al.
IMMUNOLOGY LETTERS (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Regulatory T-cell directed therapies in liver diseases
Ye Htun Oo et al.
JOURNAL OF HEPATOLOGY (2013)
Mecnanisms underlying CD4+Treg immune regulation in the adult: from experiments to models
Marta Caridade et al.
FRONTIERS IN IMMUNOLOGY (2013)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Primary biliary cirrhosis and cancer risk: A systematic review and meta-analysis
Yan Liang et al.
HEPATOLOGY (2012)
The changing scenario of hepatocellular carcinoma over the last two decades in Italy
Valentina Santi et al.
JOURNAL OF HEPATOLOGY (2012)
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Gyoergy Baffy et al.
JOURNAL OF HEPATOLOGY (2012)
Multiple Treg suppressive modules and their adaptability
James B. Wing et al.
FRONTIERS IN IMMUNOLOGY (2012)
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma
Chuen-Fei Chen et al.
GASTROENTEROLOGY (2011)
Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus-Related Cirrhosis
Ashwani K. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
A Multifaceted Imbalance of T Cells with Regulatory Function Characterizes Type 1 Autoimmune Hepatitis
Silvia Ferri et al.
HEPATOLOGY (2010)
Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C
Timothy R. Morgan et al.
HEPATOLOGY (2010)
Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma
Xiaohong Shen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Influence of Serum and Soluble CD25 (sCD25) on Regulatory and Effector T-cell Function in Hepatocellular Carcinoma
R. Cabrera et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Metabolic Syndrome and Hepatocellular Carcinoma Two Growing Epidemics With a Potential Link
Abby B. Siegel et al.
CANCER (2009)
Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients
Jia Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Diagnosis and Therapy of Autoimmune Hepatitis
Alessandro Granito et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis
Aldo J. Montano-Loza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
CD4(+)CD25(+) regulatory T cells: a therapeutic target for liver diseases
Ming-Hua Zheng et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis
Maria Serena Longhi et al.
HEPATOLOGY (2008)
Circulating CD4(+) CD25(+) regulatory T cells correlate with chronic hepatitis B infection
Guoping Peng et al.
IMMUNOLOGY (2008)
Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation
Yasushi Onishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression
Stephanie K. Bunt et al.
CANCER RESEARCH (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B
Guilin Yang et al.
INTERNATIONAL IMMUNOLOGY (2007)
FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis
Noritoshi Kobayashi et al.
CLINICAL CANCER RESEARCH (2007)
Tumor-derived CD4(+) CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10
Nicolas Larmonier et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation
Ana Izcue et al.
IMMUNOLOGICAL REVIEWS (2006)
Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B1
Dongping Xu et al.
JOURNAL OF IMMUNOLOGY (2006)
Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression
Cecilia Oderup et al.
IMMUNOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Current concepts of tumor-infiltrating lymphocytes in human malignancies
SH Chiou et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2005)
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection
T Boettler et al.
JOURNAL OF VIROLOGY (2005)
Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection
SM Rushbrook et al.
JOURNAL OF VIROLOGY (2005)
Mechanisms of suppression by suppressor T cells
H von Boehmer
NATURE IMMUNOLOGY (2005)
Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T-regulatory cells
E Unitt et al.
HEPATOLOGY (2005)
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
JN Stoop et al.
HEPATOLOGY (2005)
An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection
R Cabrera et al.
HEPATOLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
An essential role for Scurfin in CD4+CD25+ T regulatory cells
R Khattri et al.
NATURE IMMUNOLOGY (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection
K Sugimoto et al.
HEPATOLOGY (2003)
Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance
J Shimizu et al.
NATURE IMMUNOLOGY (2002)
Human CD4+CD25+ cells:: a naturally occurring population of regulatory T cells
WF Ng et al.
BLOOD (2001)
High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis
T Ishikawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
分享论文
